Heart Test Laboratories, Inc. (HSCS)
- Previous Close
5.77 - Open
5.62 - Bid 5.49 x 100
- Ask 5.89 x 100
- Day's Range
5.52 - 5.90 - 52 Week Range
5.10 - 110.00 - Volume
33,336 - Avg. Volume
46,954 - Market Cap (intraday)
3.822M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-35.00 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
67.50
Heart Test Laboratories, Inc., doing business as HeartSciences, is a medical technology company focuses on applying AI-based technology to an ECG to expand and improve an ECG's clinical utility. It is developing AI-ECG solutions to be made available on a hardware agnostic cloud-based platform or its proprietary MyoVista wavECG device, to help identify cardiovascular disease in any care setting worldwide in a manner to suit different care providers. Its first product candidate for FDA clearance, the MyoVista wavECG, or the MyoVista, is a resting 12-lead ECG that is designed to provide diagnostic information related to cardiac dysfunction. The MyoVista also provides conventional ECG information in the same test. The company was incorporated in 2007 and is headquartered in Southlake, Texas.
heartsciences.comRecent News: HSCS
Performance Overview: HSCS
Trailing total returns as of 6/7/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HSCS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HSCS
Valuation Measures
Market Cap
3.82M
Enterprise Value
-2.19M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
66.83
Price/Book (mrq)
0.44
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-52.73%
Return on Equity (ttm)
-152.61%
Revenue (ttm)
18.6k
Net Income Avi to Common (ttm)
-6.39M
Diluted EPS (ttm)
-35.00
Balance Sheet and Cash Flow
Total Cash (mrq)
7.08M
Total Debt/Equity (mrq)
12.27%
Levered Free Cash Flow (ttm)
-4.89M